Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
COMBINATION THERAPY COMPRISING IVOSIDENIB, CYTARABINE AND DAUNORUBICIN OR IDARUBICIN FOR TREATING ACUTE MYELOGENOUS LEUKEMIA
No-Receipt date
2024-02325 - 21/06/2024
No-Filing date
20240401453 - 21/06/2024
No-Granting date
3115712 - 02/07/2024
No-EPO application date
16856274.2 - 14/10/2016
No-EPO granting date
3362065 - 03/04/2024
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
7/2024 - 19/08/2024
Expiration date
15/10/2036
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201562242267 P15/10/2015/US
US201562255253 P13/11/2015/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/136
A61K 31/4439
A61K 31/444
A61K 31/704
A61K 31/7048
A61K 31/7068
A61K 45/06
A61P 35/02
C07H 19/06
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1625676
LES LABORATOIRES SERVIER
50 RUE CARNOT
92284 SURESNES CEDEX
FRANCE
Inventors
Code
Firstname
Surname
4240091
AGRESTA, SAMUEL, V.
Representatives
Code
Firstname
Surname
Address
Town
Zip
3089
NIKOLAOS
LYMPERIS "DIKIGORIKI ETAIREIA VAGIANOU KOSTOPOULOU LYMPERI"
STOURNARI 37
ATHINA (ATTIKIS)
10682
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
7915
NIKOLAOS
LYMPERIS
STOURNARI 37
ATHINA (ATTIKIS)
10682
GREECE
Owners History
Title Instruments
Payments history
9 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).